Tibet Cheezheng Tibetan Medicine Co Ltd
Tibet Cheezheng Tibetan Medicine Co., Ltd. engages in the research, development, production, and sale of Tibetan medicines in China and internationally. The company also provides plasters, topical and oral tibetan medicines, and ointments. Its products are used in areas of orthopedics, neurology, dermatology, granules, gynecology, pediatrics, respiratory, gastroenterology, cardiovascular, musculo… Read more
Tibet Cheezheng Tibetan Medicine Co Ltd (002287) - Total Liabilities
Latest total liabilities as of September 2025: CN¥1.78 Billion CNY
Based on the latest financial reports, Tibet Cheezheng Tibetan Medicine Co Ltd (002287) has total liabilities worth CN¥1.78 Billion CNY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Tibet Cheezheng Tibetan Medicine Co Ltd - Total Liabilities Trend (2006–2024)
This chart illustrates how Tibet Cheezheng Tibetan Medicine Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Tibet Cheezheng Tibetan Medicine Co Ltd Competitors by Total Liabilities
The table below lists competitors of Tibet Cheezheng Tibetan Medicine Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
SK Networks Co Ltd
KO:001740
|
Korea | ₩3.22 Trillion |
|
OPUS GLOBAL Nyrt
BUD:OPUS
|
Hungary | Ft602.11 Billion |
|
Semler Scientific Inc
NASDAQ:SMLR
|
USA | $136.93 Million |
|
SMO ClinPlus Co. Ltd.
SHE:301257
|
China | CN¥247.77 Million |
|
ThredUp Inc
NASDAQ:TDUP
|
USA | $113.40 Million |
|
Hubei Sanxia New Building Materials Co Ltd
SHG:600293
|
China | CN¥1.48 Billion |
|
ZEAL Network SE
XETRA:TIMA
|
Germany | €212.18 Million |
|
Johnson Health Tech Co Ltd
TW:1736
|
Taiwan | NT$33.23 Billion |
Liability Composition Analysis (2006–2024)
This chart breaks down Tibet Cheezheng Tibetan Medicine Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.63 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.37 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.27 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Tibet Cheezheng Tibetan Medicine Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Tibet Cheezheng Tibetan Medicine Co Ltd (2006–2024)
The table below shows the annual total liabilities of Tibet Cheezheng Tibetan Medicine Co Ltd from 2006 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥2.68 Billion | +5.88% |
| 2023-12-31 | CN¥2.53 Billion | +1.17% |
| 2022-12-31 | CN¥2.50 Billion | +6.46% |
| 2021-12-31 | CN¥2.35 Billion | +28.66% |
| 2020-12-31 | CN¥1.82 Billion | +152.63% |
| 2019-12-31 | CN¥722.20 Million | +169.94% |
| 2018-12-31 | CN¥267.54 Million | -33.58% |
| 2017-12-31 | CN¥402.78 Million | +24.19% |
| 2016-12-31 | CN¥324.33 Million | -22.60% |
| 2015-12-31 | CN¥419.05 Million | +73.02% |
| 2014-12-31 | CN¥242.20 Million | +180.51% |
| 2013-12-31 | CN¥86.34 Million | +6.73% |
| 2012-12-31 | CN¥80.90 Million | +1.11% |
| 2011-12-31 | CN¥80.01 Million | -27.74% |
| 2010-12-31 | CN¥110.72 Million | -27.48% |
| 2009-12-31 | CN¥152.68 Million | +54.18% |
| 2008-12-31 | CN¥99.02 Million | -16.35% |
| 2007-12-31 | CN¥118.37 Million | -11.91% |
| 2006-12-31 | CN¥134.37 Million | -- |